Skip to main content
. 2009 Dec 26;25(1):110–116. doi: 10.3346/jkms.2010.25.1.110

Table 3.

Clinical profiles of patients with no increase in FSH or LH 3 months after completion of chemotherapy (Group A) and patients with increased FSH and LH 3 months after completion of chemotherapy (Group B)

graphic file with name jkms-25-110-i003.jpg

Data are expressed as mean±SD.

P values by independent t-test or Fisher's exact test.

Group A, Patients with no increase in FSH or LH 3 months after completion of chemotherapy; Group B, Patients with a significant increase in FSH and LH 3 months after completion of chemotherapy.

Each values of gonadotropin (FSH/LH) were 38.4/14.0, 51.1/17.0, 37.9/16.2 and 70.9/26.8 mIU/mL in Group B.

FSH, follicle stimulating hormone; BMI, body mass index; BCS, breast consening surgery; MRM, modified radical mastectomy; TM, total mastectomy; AC, doxorubicin, cyclophosphamide; CAF, cyclophosphamide doxorubicin, 5-Fluorouracil.